Obesity and renal impairment in patients with heart failure and reduced ejection fraction: another obesity paradox?

被引：0
|
作者：
Matsumoto, S. [1 ]
Henderson, A. D. [1 ]
Shen, L. [1 ]
Desai, A. S. [2 ]
Swedberg, K. [3 ]
Claggett, B. L. [2 ]
Lefkowitz, M. P. [4 ]
Rouleau, J. L. [5 ]
Vaduganathan, M. [2 ]
Packer, M. [6 ]
Zile, M. R. [7 ]
Jhund, P. S. [1 ]
Solomon, S. D. [2 ]
Mcmurray, J. J., V [1 ]
机构：
[1] BHF Glasgow Cardiovasc Res Ctr, Glasgow, Scotland
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[3] Univ Gothenburg, Gothenburg, Sweden
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Univ Montreal, Montreal, PQ, Canada
[6] Baylor Univ, Med Ctr, Dallas, TX USA
[7] Med Univ South Carolina, Charleston, SC USA
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1175
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Obesity paradox in patients with reduced ejection fraction eligible for device implantation - an observational study
    Merkel, Eperke D.
    Behon, Anett
    Masszi, Richard
    Schwertner, Walter R.
    Kuthi, Luca
    Veres, Boglarka
    Osztheimer, Istvan
    Papp, Roland
    Molnar, Levente
    Zima, Endre
    Geller, Laszlo
    Kosztin, Annamaria
    Merkely, Bela
    ESC HEART FAILURE, 2024, 11 (06): : 3616 - 3625
  • [32] Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
    Kirkman, Danielle L.
    Bohmke, Natalie
    Billingsley, Hayley E.
    Carbone, Salvatore
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [33] Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
    Packer, Milton
    Zile, Michael R.
    Kramer, Christopher M.
    Baum, Seth J.
    Litwin, Sheldon E.
    Menon, Venu
    Ge, Junbo
    Weerakkody, Govinda J.
    Ou, Yang
    Bunck, Mathijs C.
    Hurt, Karla C.
    Murakami, Masahiro
    Borlaug, Barry A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [34] Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity
    Wagner, Jeffrey
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (25): : 2398 - 2398
  • [35] Obesity and the Obesity Paradox in Heart Failure
    Horwich, Tamara B.
    Fonarow, Gregg C.
    Clark, Adrienne L.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 61 (02) : 151 - 156
  • [36] Obesity and the Obesity Paradox in Heart Failure
    Gupta, Pritha P.
    Fonarow, Gregg C.
    Horwich, Tamara B.
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (02) : 195 - 202
  • [37] Obesity and the Obesity Paradox in Heart Failure
    Clark, Adrienne L.
    Fonarow, Gregg C.
    Horwich, Tamara B.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2014, 56 (04) : 409 - 414
  • [38] Proteomic biomarkers related to obesity in heart failure with reduced ejection fraction and their associations with outcome
    Petersen, Teun B.
    Suthahar, Navin
    Asselbergs, Folkert W.
    de Bakker, Marie
    Akkerhuis, K. Martijn
    Constantinescu, Alina A.
    van Ramshorst, Jan
    Katsikis, Peter D.
    van Der Spek, Peter J.
    Umans, Victor A.
    de Boer, Rudolf A.
    Boersma, Eric
    Rizopoulos, Dimitris
    Kardys, Isabella
    OBESITY, 2024, 32 (09) : 1658 - 1669
  • [39] No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter Study
    Cassado-Valls, Paula
    Enjuanes, Cristina
    Anguita, Manuel
    Formiga, Francesc
    Almenar, Luis
    Crespo-Leiro, Maria G.
    Manzano, Luis
    Muniz, Javier
    Chaves, Jose
    Hidalgo, Encarna
    Ramos-Polo, Raul
    Yun, Sergi
    Jose-Bazan, Nuria
    Moliner, Pedro
    Comin-Colet, Josep
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (24)
  • [40] Tirzepatide for Patients With Heart Failure With Preserved Ejection Fraction and Obesity: the SUMMIT Trial
    Packer, Milton
    CIRCULATION, 2024, 150 (25) : E714 - E714
12345